EN | ΕΛ
Browse Helios by "Author"
Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page
Showing results 1 to 12 of 12

DateTitleAuthor(s)Full text
2006A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg(91), Ala(96)] MBP87-99Mantzourani, E. D.; Tselios, T. V.; Grdadolnik, S. G.; Brancale, A.; Platts, J. A.; Matsoukas, J. M.; Mavromoustakos, Thomas
2006Comparison of proposed putative active conformations of myelin basic protein epitope 87-99 linear altered peptide ligands by spectroscopic and modelling studies: The role of positions 91 and 96 in T-cell receptor activationMantzourani, E. D.; Tselios, T. V.; Grdadolnik, S. G.; Platts, J. A.; Brancale, A.; Deraos, G. N.; Matsoukas, J. M.; Mavromoustakos, Thomas
2006Structure elucidation and conformational study of V8 - A novel synthetic non peptide AT(1) antagonistZoumpoulakis, Panagiotis; Politi, A.; Grdadolnik, S. G.; Matsoukas, J.; Mavromoustakos, Thomas
20052D NMR and conformational analysis of a prototype anti-tumour steroidal esterKapou, A.; Fousteris, M. A.; Nikolaropoulos, S. S.; Zervou, Maria; Grdadolnik, S. G.; Zoumpoulakis, Panagiotis; Kyrikou, L.; Mavromoustakos, Thomas
2004Conformation and bioactivity. Design and discovery of novel antihypertensive drugsMavromoustakos, Thomas; Zervou, Maria; Zoumpoulakis, Panagiotis; Kyrikou, I.; Benetis, N. P.; Polevaya, L.; Roumelioti, P.; Giatas, N.; Zoga, A.; Minakakis, P. M.; Kolocouris, A.; Vlahakos, D.; Grdadolnik, S. G.; Matsoukas, J.
2003Antileishmanial ring-substituted ether phospholipidsAvlonitis, N.; Lekka, E.; Detsi, A.; Koufaki, Maria; Calogeropoulou, Theodora; Scoulica, E.; Siapi, E.; Kyrikou, I.; Mavromoustakos, Thomas; Tsotinis, A.; Grdadolnik, S. G.; Makriyannis, A.
2003Structural elucidation and conformational properties of the toxin paralysin beta-Ala-TyrKyrikou, I.; Grdadolnik, S. G.; Tatari, M.; Poulos, C.; Mavromoustakos, Thomas
2003Conformational and biological studies for a pair of novel synthetic AT(1) antagonists: stereoelectronic requirements for antihypertensive efficacyZoumpoulakis, Panagiotis; Zoga, A.; Roumelioti, P.; Giatas, N.; Grdadolnik, S. G.; Iliodromitis, E.; Vlahakos, D.; Kremastinos, D.; Matsoukas, J. M.; Mavromoustakos, Thomas
2002Structure elucidation and conformational properties of eprosartan a non peptide Angiotensin II AT(1) antagonistZoumpoulakis, Panagiotis; Grdadolnik, S. G.; Matsoukas, J.; Mavromoustakos, Thomas
2002Design, synthesis and biological evaluation of cyclic Angiotensin II analogues with 3,5 side-chain bridges: Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonistsRoumelioti, P.; Polevaya, L.; Zoumpoulakis, Panagiotis; Giatas, N.; Mutule, I.; Keivish, T.; Zoga, A.; Vlahakos, D.; Iliodromitis, E.; Kremastinos, D.; Grdadolnik, S. G.; Mavromoustakos, Thomas; Matsoukas, J.
2001Structure elucidation and conformational properties of a novel bioactive clerodane diterpene using a combination of high field NMR spectroscopy, computational analysis and X-ray diffractionKolocouris, A.; Mavromoustakos, Thomas; Demetzos, C.; Terzis, A.; Grdadolnik, S. G.
2001Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*-pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonistsPolevaya, L.; Mavromoustakos, Thomas; Zoumpoulakis, Panagiotis; Grdadolnik, S. G.; Roumelioti, P.; Giatas, N.; Mutule, I.; Keivish, T.; Vlahakos, D. V.; Iliodromitis, E. K.; Kremastinos, D. T.; Matsoukas, J.
Showing results 1 to 12 of 12



 

Follow EKT at: